OROSOL : treatment for oral mucositis

Overview

OROSOL is a revolutionary product designed to provide relief and treatment for oral mucositis induced by radiotherapy or chemotherapy. This throat spray, presented in a 20ml bottle, targets pro-inflammatory proteins, contaminants, and impurities, offering a threefold action for optimal results.

Mode of action

Protective Barrier Effect:

MucositisOROSOL creates a protective barrier in the oral cavity, shielding the mucous membranes from further damage and allowing the healing process to begin.

Osmotic and Cleaning Effect:

The product works to cleanse the oral cavity, removing impurities and contaminants that can exacerbate inflammation and delay healing.

Cellular Repair and Growth Effect:

MucositisOROSOL promotes the repair and growth of cells in the oral cavity, accelerating the healing process and reducing the duration of symptoms.

Clinical Trial

In a randomized, double-blind, placebo-controlled clinical trial conducted over six weeks, MucositisOROSOL demonstrated significant efficacy. Patients experienced a 23% reduction in mucus in just two days, and a 35% reduction in mucositis in three days. By the end of one month, mucositis was reduced by 69%.

The product also showed remarkable results in pain management, with a 34% reduction in pain in just 20 minutes, and a 72% reduction in pain by the end of one month.

In addition to its effects on mucositis and pain, OROSOL also demonstrated a significant reduction in burns and infections associated with oral mucositis. By the end of one month, burns were reduced by 74%, and infections were reduced by 75%.

These results highlight the potential of OROSOL as a powerful tool in the management of oral mucositis induced by radiotherapy or chemotherapy. Its multi-faceted approach not only alleviates symptoms but also promotes healing, offering patients a more comfortable and swift recovery.

See full publication (PDF)